CN Patent

CN118434727A — 取代的嘧啶酮衍生物、其药物组合物及医药上的用途

Assigned to Yangtze River Pharmaceutical Group Co Ltd · Expires 2024-08-02 · 2y expired

What this patent protects

本申请涉及取代的嘧啶酮衍生物、其药学上可接受的盐、立体异构体、药物组合物以及医药上的用途。所述取代的嘧啶酮衍生物为具有式(I)所示的结构的化合物，所述化合物具有显著的CSF‑1R选择性抑制活性，十分具有实用价值。

USPTO Abstract

本申请涉及取代的嘧啶酮衍生物、其药学上可接受的盐、立体异构体、药物组合物以及医药上的用途。所述取代的嘧啶酮衍生物为具有式(I)所示的结构的化合物，所述化合物具有显著的CSF‑1R选择性抑制活性，十分具有实用价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN118434727A
Jurisdiction
CN
Classification
—
Expires
2024-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Yangtze River Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.